Study explores how DMT and meditation shape retreat experiences

What this retreat actually tested

A meditation retreat became a laboratory for one very specific question: what changes when an intense contemplative setting meets a psychedelic, and what stays the same. Milan Scheidegger and the Psychedelic Research & Therapy Development group at the University of Zurich and Psychiatric University Clinic Zurich built the study around an intensive three-day mindfulness retreat with experienced meditators, not beginners, which matters because the participants already knew how to sit with attention, silence, and discomfort.

The design was tightly controlled from the start. The registered trial, NCT05780216, was a completed early-phase 1 interventional study with 40 enrolled experienced meditators, randomly assigned to DMT/harmine or placebo in a double-blind setup. It ran from February 20, 2023 to September 15, 2023, and included functional MRI imaging, psychometric assessments before and after the retreat, and detailed experiential interviews after the sessions.

How the study was built

The main thing to understand is that this was not a loose “psychedelics plus mindfulness” experiment. Participants stayed in the retreat container throughout, continued meditating, and on the second day received incremental doses of DMT-harmine or placebo while the practice itself continued around them. That combination of retreat structure, blinded dosing, and repeated assessment is what makes the work interesting, but also what makes it impossible to copy casually.

The Scientific Reports paper published on March 18, 2026 says it was the first application of natural language processing in a mixed-method framework for structured phenomenological interviews in an ecologically valid randomized controlled trial of psychedelic-augmented meditation. In plain language, the researchers did not stop at questionnaires. They listened to how people described the experience, then analyzed that language with qualitative methods and NLP, which is a much better way to catch how a retreat is actually lived, not just how it scores on a scale.

That methodological choice is the heart of the story. When you are studying meditation and psychedelics together, the point is not only whether someone reported a bigger effect. It is whether the retreat context, the participant’s training, the language they already use to make sense of practice, and the substance itself all braid together into one experience.

What participants reported in the retreat setting

The two groups often used surprisingly similar language, especially language rooted in Buddhist concepts like attention, acceptance, and impermanence. That suggests the retreat did not disappear under the drug condition. Instead, it provided a shared contemplative frame that shaped how both groups narrated what happened.

The differences were still clear. The DMT-harmine group reported more intense perceptual changes, stronger emotions, richer visual imagery, and more dramatic shifts in self-perception. The placebo group, by contrast, more often described moderate bodily sensations, emotional regulation, and features of the retreat environment such as music and setting. That is a useful reminder for anyone who tends to flatten mystical or psychedelic experiences into chemistry alone: the room, the ritual, and the practice style all leave fingerprints on what gets noticed.

For mindfulness readers, that is the real boundary line. Meditation does not make a psychedelic experience pure, and a psychedelic does not erase the training that comes from years of sitting. What the study suggests is that contemplative practice can act like a lens, shaping the texture and interpretation of altered states rather than simply sitting beside them as background decoration.

What the earlier outcomes paper adds

The earlier placebo-controlled outcomes paper, published in the Journal of Psychopharmacology on September 27, 2024, gives the cleaner headline results. During the acute phase, the DMT-harmine group self-attributed greater mystical-type experiences, non-dual awareness, and emotional breakthrough, and one day later they reported greater psychological insight after baseline correction. At one-month follow-up, that same group rated the retreat as more personally meaningful, spiritually significant, and well-being-enhancing.

There is an important catch, and it keeps this story from drifting into hype. The same paper found no significant group difference in mindfulness or compassion. So if someone hears “meditation and psychedelics” and assumes the combination automatically makes you more mindful, the data do not support that simplification. The more honest reading is narrower and more interesting: the intervention changed the quality and meaning of the experience, but not every outcome people often assume should move together.

What not to try on your own

This is the part that matters most if you are tempted to treat the study like a blueprint. It is not one. The retreat was run in a clinical, double-blind, research environment with screening, monitoring, MRI, psychometrics, and experienced meditators inside a carefully maintained container.

Do not try to imitate it casually, and especially do not try to recreate the dosing pattern on your own. The obvious risks are not abstract here:

• DMT-harmine was administered in a controlled research setting, not as a self-guided retreat add-on.
• The participants were experienced meditators, not people testing altered states for the first time.
• The study used blinding, clinical oversight, and structured assessments that you cannot replicate at home.
• The interaction between meditation, expectation, setting, and psychedelics is still not fully understood from a safety standpoint.
• A powerful retreat experience is not the same thing as a safe or transferable practice.

That last point is the one people miss when they read about mystical-type experiences and assume more intensity is automatically better. The study shows that meditation can shape how psychedelic states are experienced and described, but it does not turn those states into a meditation tool for everyday use.

What to take from it if you actually practice

If you spend time in mindfulness, the practical lesson is less about compounds and more about conditions. The retreat’s biggest finding is that experience is shaped by training, context, and interpretation, not just by whatever is happening in the nervous system at the moment. That is exactly why this work feels useful to the field without becoming an advertisement for experimentation.

For your own practice, the takeaway is concrete: pay closer attention to the container around practice, not just the technique itself. The seat you choose, the continuity of your schedule, the teacher or retreat structure, and the way you integrate what comes up afterward can matter more than chasing a bigger state. That is the part of the study that survives outside the research room, and it is the only part worth bringing home.